Prochlorperazine
Prochlorperazine
- Available from many community pharmacies and online vendors; while prochlorperazine is prescription-only in most jurisdictions (Rx), some local pharmacies or online suppliers may supply it without a prescription or receipt—availability varies by country and seller.
- Prochlorperazine is used for severe nausea and vomiting, and as an antipsychotic for schizophrenia and short-term treatment of severe anxiety; it works primarily as a dopamine (D2) receptor antagonist, blocking dopamine pathways in the brain and the chemoreceptor trigger zone to reduce emesis and psychotic symptoms.
- Usual adult doses: for nausea/vomiting 5–10 mg orally 3–4 times daily or 5–10 mg IM/IV 1–2 times daily; for psychosis 5–10 mg orally 3–4 times daily with titration (maximum commonly cited up to 150 mg/day in divided doses); pediatric dosing is lower and weight-based—refer to labelling.
- Administered orally (tablets, oral solution/syrup), as rectal suppositories, or by injection (IM/IV) in hospital settings.
- Onset of effect: oral typically within 15–60 minutes, IM within 10–30 minutes, and IV within minutes.
- Duration of action varies by route and dose but is generally about 4–12 hours for antiemetic effects; antipsychotic effects depend on dosing and duration of therapy.
- Alcohol warning: avoid alcohol—concurrent use increases sedation, dizziness and risk of respiratory or cardiovascular depression.
- The most common side effect is drowsiness/sedation; other frequent effects include extrapyramidal symptoms (tremor, restlessness, dystonia), dry mouth, constipation, hypotension and photosensitivity.
- Would you like to try prochlorperazine without a prescription?
Basic Prochlorperazine Information
- INN (International Nonproprietary Name): Prochlorperazine.
- Brand Names Available In Canada (English): Compazine has historically been used in Canada and generics are broadly available.
- ATC Code: N05AB04 — phenothiazines with piperazine structure.
- Forms & Dosages: Tablets 5 mg and 10 mg are commonly available.
- Forms & Dosages: Suppositories, often 25 mg, are listed in product sources.
- Forms & Dosages: Injectable ampoules/vials for IM/IV use (examples include 5 mg/mL and 12.5 mg/mL) are used in hospitals.
- Forms & Dosages: Oral solution/syrup formulations such as 5 mg/5 mL are listed in supplier data.
- Manufacturers In Canada (English): Generics from manufacturers such as Heritage Pharmaceuticals, Teva, Sandoz and other multinational suppliers are commonly distributed.
- Registration Status In Canada (English): Not specified in the source data for specific Health Canada market authorizations.
- OTC / Rx Classification: Prescription Only (Rx) in major jurisdictions and listed as prescription-only in the source data.
- Standard Dosages Per Condition: Severe nausea/vomiting — 5–10 mg orally 3–4 times daily or 5–10 mg IM/IV 1–2 times daily.
- Standard Dosages Per Condition: Schizophrenia/psychosis — start 5–10 mg orally 3–4 times daily and titrate per clinical response.
- Standard Dosages Per Condition: Pediatric examples in sources include ~0.13 mg/kg orally every 6–8 hours for antiemetic use, with specialist oversight required.
- Population Dosing Adjustments: Use lower doses for children and avoid routine use under 2 years or under 10 kg without specialist approval.
- Population Dosing Adjustments: Elderly should receive the lowest effective dose with close monitoring for sedation, hypotension and extrapyramidal symptoms.
- Typical Treatment Durations: Nausea and vomiting are usually treated with short courses, often less than 7 days.
- Typical Treatment Durations: Psychiatric indications require review at 2–4 weeks and long-term therapy is under specialist monitoring.
- Missed Dose Instructions: Take as soon as remembered unless it is near the next dose; do not double doses.
- Overdose Management: Signs include CNS depression, respiratory depression, hypotension and extrapyramidal effects; management is supportive with ICU care as needed.
- Storage & Transport Guidelines: Store at room temperature (15–30°C) and protect from moisture and light.
- Absolute Contraindications: Known hypersensitivity to prochlorperazine or other phenothiazines, comatose patients, children under 2 years or under 10 kg for oral use, and known bone marrow depression.
- Relative Contraindications: Use caution in elderly (increased mortality in dementia-related psychosis), Parkinson disease, severe hepatic/renal impairment, epilepsy and severe cardiovascular disease.
- Common Side Effects: Drowsiness, dizziness, blurred vision, dry mouth, constipation, hypotension, photosensitivity, weight gain and extrapyramidal symptoms such as tremor, dystonia and akathisia.
- Market Alternatives: Common comparator medicines include ondansetron, metoclopramide, haloperidol and promethazine.
Critical Warnings And Restrictions In Canada
High-Risk Groups Elderly Pregnant Indigenous Health Considerations
Who should be cautious or avoid prochlorperazine?
Prochlorperazine is a prescription-only antipsychotic/antiemetic that carries important risks for defined groups.
Elderly patients have higher risks of sedation, orthostatic hypotension, extrapyramidal symptoms and increased mortality when used for dementia-related psychosis.
Pregnancy and breastfeeding: avoid unless benefits clearly outweigh risks and obstetrical advice supports use.
Children: avoid routine use under 2 years or in children under 10 kg unless a specialist prescribes and documents dosing.
Indigenous and remote communities require culturally safe informed consent and access to follow-up and emergency care.
- Contraindication Checklist: Known allergy to prochlorperazine or other phenothiazines.
- Contraindication Checklist: Comatose state or severe CNS depression.
- Contraindication Checklist: Children under 2 years or under 10 kg for oral formulations unless specialist-approved.
- Monitoring Steps Checklist: Start elderly patients on the lowest effective dose and arrange close follow-up within days.
- Monitoring Steps Checklist: For pregnancy or breastfeeding, document informed consent and consult obstetrical care.
- Monitoring Steps Checklist: Ensure emergency access and clear instructions for remote or Indigenous patients when prescribing outside urban centres.
Interaction With Activities Driving Machinery Workplace Safety Under Canadian Law
How will prochlorperazine affect daily activities such as driving or operating machinery?
Prochlorperazine commonly causes sedation, blurred vision and dizziness that can impair driving and workplace safety.
If sedation or orthostatic symptoms occur, do not drive, operate heavy machinery or perform safety-sensitive tasks.
Employers and occupational health must consider the duty-to-accommodate for employees and may restrict safety-sensitive roles while on CNS-active drugs.
Q&A — Can I Drive After Taking It In Canada?
Short answer: No until you know how it affects you.
If you feel sleepy, dizzy or light-headed after a dose, do not drive or operate machinery.
Check provincial impaired-driving rules and follow workplace safety policies before returning to safety-sensitive duties.
Usage Basics For Canadians
INN Brand Names Available In Canada
What names will prochlorperazine appear under in Canada?
INN: prochlorperazine is the International Nonproprietary Name used on clinical and regulatory documents.
Compazine has historically been used in Canada and generic prochlorperazine tablets, injectables and suppositories are commonly available.
Typical tablet strengths are 5 mg and 10 mg and other forms include suppositories and injectables used in hospitals.
The ATC code N05AB04 classifies prochlorperazine as a phenothiazine with a piperazine side chain.
Legal Classification Under Health Canada Prescription Vs OTC
Is prochlorperazine available without a prescription in Canada?
The drug is classified as prescription-only (Rx) in major jurisdictions and should be dispensed with a valid prescription across Canada.
- Typical Forms Available: Tablets (5 mg, 10 mg).
- Typical Forms Available: Suppositories (for patients unable to take oral medication).
- Typical Forms Available: Injectable vials/ampoules for IM/IV hospital use.
- Typical Forms Available: Oral solution/syrup formulations exist in some product listings.
- Where To Confirm DIN/Label Info: Check the product label for a Health Canada DIN or ask your pharmacist to confirm the DIN when dispensing.
Practical note: pharmacists working in national chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu can confirm local stock and discuss substitution to available generics.
Canadian Dosing Guide
Standard Regimens Health Canada Approved
How is prochlorperazine usually dosed for adults?
For severe nausea and vomiting, common adult dosing is 5–10 mg orally three to four times daily.
For IM or IV administration in acute settings, 5–10 mg once or twice daily is typical in hospital practice.
For psychotic disorders, initial oral doses of 5–10 mg three to four times daily are used and titrated to clinical response with specialist oversight.
Pediatric dosing varies by age and weight and specialist guidance is advised; some listings show approximately 0.13 mg/kg orally every 6–8 hours for antiemetic use.
Adjustments For Comorbidities Diabetes Cardiovascular Hepatic
What adjustments are needed for elderly or medically complex patients?
Start the elderly at the lowest effective dose and monitor closely for sedation, hypotension and extrapyramidal symptoms.
Patients with hepatic or renal impairment may require dose reduction and more frequent monitoring due to reduced clearance.
Antipsychotics can affect weight and glucose control; baseline metabolic screening and periodic monitoring are advised for long-term therapy.
Q&A — What If I Miss A Dose Under My Provincial Drug Plan?
Take the missed dose as soon as you remember unless it is almost time for the next dose, and do not double doses.
If you run out of medication and need an emergency refill, contact your pharmacist who can advise on provincial procedures such as emergency supply rules for ODB, PharmaCare or RAMQ.
| Indication | Typical Adult Dose | Typical Duration / Notes |
|---|---|---|
| Severe Nausea/Vomiting | 5–10 mg orally 3–4× daily; 5–10 mg IM/IV 1–2× daily | Short course; often <7 days |
| Acute Psychosis/Schizophrenia | 5–10 mg orally 3–4× daily, titrate | Review within 2–4 weeks; specialist follow-up for long-term use |
| Non-Psychotic Anxiety (Short-Term) | 5 mg 3–4× daily (max ~20 mg/day) | Short-term only; not typically a first-line option |
- Dose Adjustment Checklist: Reduce dose in hepatic or renal impairment.
- Dose Adjustment Checklist: Use lowest effective dose in elderly and monitor blood pressure and movement disorders.
- Dose Adjustment Checklist: Avoid or use caution in patients with seizure disorder and review other CNS-active medicines.
Interaction Chart Canadian Context
Food And Drinks Coffee Alcohol In Canadian Lifestyle
Can common beverages affect how prochlorperazine works?
Alcohol potentiates central nervous system depression and increases sedation and risk of orthostatic hypotension while taking prochlorperazine.
Caffeine may temporarily mask sedation but does not prevent movement-related adverse effects or orthostatic risk.
- Avoid or limit alcohol while taking prochlorperazine.
- Be cautious using caffeinated beverages to "counteract" drowsiness; they do not reverse motor side effects.
- If drowsiness persists despite avoiding alcohol, discuss alternatives with a pharmacist.
Common Drug Conflicts Refer To Health Canada Advisories
Which medicines commonly interact with prochlorperazine?
| Interaction | Effect | Recommended Action |
|---|---|---|
| Other CNS depressants (opioids, benzodiazepines) | Increased sedation and respiratory depression risk | Avoid co-prescription or reduce doses and monitor closely |
| Anticholinergic drugs | Additive dry mouth, constipation and blurred vision | Monitor symptoms and adjust therapy as needed |
| QT-prolonging medicines | Potential additive risk of arrhythmia | Check ECG if patient has cardiac history and consult prescriber |
| Levodopa and dopamine agonists | Pharmacologic antagonism reduces antiparkinson effect | Avoid unless specialist advises and monitor motor function |
Consult a pharmacist or prescriber before starting new prescription or over-the-counter medicines with prochlorperazine.
User Reports And Trends In Canada
Canadian Patient Forums And Review Platforms
What are patients saying online about prochlorperazine in Canada?
Patient reports commonly note effective relief of severe nausea and vertigo symptoms with prochlorperazine.
Consistent patient concerns include sedation, akathisia, dystonic reactions and residual drowsiness after doses.
Accessibility and switching to generics after brand discontinuations are common themes in community discussions.
Community Pharmacy Feedback
How do pharmacists describe local use?
Pharmacists report frequent use of prochlorperazine in emergency departments for acute vomiting when ondansetron is not indicated or available.
Community pharmacists emphasise counselling on early recognition of extrapyramidal symptoms and the need for urgent care if severe movement reactions occur.
- Top Patient-Reported Benefits: Effective antiemetic for acute severe nausea and vestibular symptoms.
- Top Patient-Reported Harms: Sedation, movement disorders such as akathisia and dystonia, and orthostatic dizziness.
| Reported Side Effect | Anecdotal Frequency |
|---|---|
| Drowsiness | Common (frequent mentions) |
| Akathisia / Restlessness | Occasional |
| Dystonia / Acute Muscle Spasm | Less frequent but urgent when present |
Access And Purchase Options
National Pharmacy Chains And In-Store Realities
Where can Canadians get prochlorperazine?
Prochlorperazine is prescription-only at community pharmacies including Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu, and it is stocked on many hospital formularies.
Generics from companies such as Teva, Sandoz and Heritage are commonly distributed.
Online Pharmacies In Canada Provincial Restrictions
How do online pharmacies handle prescriptions in Canada?
Canadian-licensed online pharmacies will fill an Rx electronically or via fax and require a valid prescription before dispensing.
Out-of-country imports are restricted and Health Canada rules apply to imported medicines.
- Checklist To Obtain Prochlorperazine: 1) Get an authorised prescription from your prescriber.
- Checklist To Obtain Prochlorperazine: 2) Confirm the DIN and product form with the dispensing pharmacist.
- Checklist To Obtain Prochlorperazine: 3) Check provincial drug plan coverage and potential prior authorization.
- Checklist To Obtain Prochlorperazine: 4) Request counselling on side effects, driving and when to seek urgent care.
For remote or Indigenous patients, ask about telemedicine follow-up and clear emergency plans before starting therapy.
In our online pharmacy, prochlorperazine is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Mechanism And Pharmacology
Simplified Explanation Patient-Friendly
How does prochlorperazine reduce nausea?
Prochlorperazine blocks dopamine D2 receptors in the brain, including the chemoreceptor trigger zone, which reduces nausea and vomiting.
The same dopamine blockade gives the drug antipsychotic effects and also explains movement-related side effects.
Clinical Terms Health Canada Monograph References
What are the terms clinicians use for side effects?
D2 antagonist: a drug that blocks dopamine D2 receptors and reduces dopaminergic activity.
Extrapyramidal symptoms: movement disorders such as tremor, dystonia or akathisia caused by dopamine blockade.
Orthostatic hypotension: a drop in blood pressure on standing that can cause dizziness and falls.
Suggested patient-leaflet diagram: a simple visual showing the chemoreceptor trigger zone in the brainstem and the action of D2 blockade to reduce nausea.
Indications And Off-Label Uses In Canada
Approved Indications DIN Label
What is prochlorperazine licensed to treat?
Approved uses listed in source material include severe nausea and vomiting and treatment of psychotic disorders such as schizophrenia.
Some labels include short-term use for non-psychotic anxiety, depending on the local product monograph.
Available formulations include tablets (5 mg, 10 mg), suppositories and injectables.
Common Off-Label Practices Canadian Physicians
When do prescribers use prochlorperazine off-label?
Off-label uses may include refractory migraine-associated nausea, vestibular-origin severe vomiting and palliative care when first-line antiemetics fail.
Such off-label prescribing should be accompanied by informed consent and clear monitoring plans.
| Indication | Typical Dose Range | Level Of Evidence / Duration |
|---|---|---|
| Nausea/Vomiting | 5–10 mg orally 3–4× daily | Short-term; common acute use |
| Migraine-Associated Nausea (Off-Label) | 5–10 mg orally or parenteral | Used when other antiemetics fail; specialist judgement |
| Palliative Care (Refractory Symptoms) | Individualized doses; often low and titrated | Off-label but common in resource-limited settings with documentation |
Key Clinical Findings
Canadian And International Studies 2022–2025
What does recent evidence say about prochlorperazine?
Recent literature continues to support prochlorperazine as an effective antiemetic in acute settings.
Comparative trials often favour ondansetron for chemotherapy- or postoperative-induced nausea, but prochlorperazine remains effective and lower-cost in many contexts.
Safety data emphasise extrapyramidal risks and the need for metabolic and cardiovascular monitoring in long-term antipsychotic use.
Ongoing Health Canada Safety Monitoring
How are adverse events tracked in Canada?
Adverse events should be reported to Canada Vigilance and prescribers should monitor for neuroleptic malignant syndrome, tardive dyskinesia and severe dystonia.
- Key Safety Signals: Acute dystonia, akathisia and parkinsonism with early treatment.
- Key Safety Signals: Metabolic changes and cardiovascular risk with long-term use.
- Monitoring Intervals: Review psychiatric indications within 2–4 weeks and perform periodic metabolic screening if therapy is continued long-term.
- Emergency Signs Checklist: Severe, sustained muscle stiffness or spasms — go to emergency.
- Emergency Signs Checklist: High fever and rigidity suggest possible NMS — urgent ED transfer.
- Emergency Signs Checklist: New or worsening breathing difficulty, chest pain or fainting — call emergency services.
Alternatives Matrix
Comparable Medicines With DIN In Canada
What alternatives should clinicians consider?
Common alternatives include ondansetron, metoclopramide, haloperidol and promethazine.
Each alternative has different mechanisms, benefits and risk profiles depending on the indication and patient comorbidities.
Pros And Cons Checklist
| Drug | Indication | Pros | Cons |
|---|---|---|---|
| Ondansetron | Chemotherapy, postoperative nausea | Well tolerated; less EPS | Higher cost; QT prolongation caution in some patients |
| Metoclopramide | GI prokinetic antiemetic | Prokinetic benefits for gastric stasis | EPS risk; caution in children and elderly |
| Haloperidol | Severe emesis and psychosis | Effective for severe symptoms | High EPS risk; requires monitoring |
| Promethazine | Antiemetic, sedation | Effective antiemetic; sedating for acute agitation | Marked sedation and anticholinergic effects |
When choosing an alternative, consider pregnancy status, age, cardiac history and interacting medications.
Common Questions From Canadian Patients
- Is It Safe In Pregnancy?: Generally avoid unless necessary; discuss risks and benefits with obstetrical care.
- Will It Make Me Sleepy?: Yes; avoid driving and heavy machinery until you know the effect.
- How Long Can I Take It For Nausea?: Short courses are typical, often less than seven days unless directed otherwise.
- What About Children?: Use specialist guidance; avoid under age two or under ten kilograms without specialist approval.
- How Do I Report Side Effects?: Contact your prescriber or pharmacist and report serious reactions to Canada Vigilance.
- When To Call Your Pharmacist Or Doctor: Severe akathisia or uncontrollable restlessness.
- When To Call Your Pharmacist Or Doctor: Acute dystonic reactions causing airway compromise or severe muscle spasm.
- When To Call Your Pharmacist Or Doctor: High fever, extreme rigidity or difficulty breathing.
Coverage And Purchase Comparison Table
Province And Plan Coverage Guidance
Does public coverage vary across Canada?
Coverage for prochlorperazine varies by province and by specific provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ.
Patients should verify coverage details with their pharmacist or plan provider before filling a prescription.
| Province/Plan | Formulation Covered | Prior Authorization Needed? | Typical Patient Cost / Notes |
|---|---|---|---|
| Ontario (ODB) | Tablets, injectables in hospital | Varies by indication | Coverage depends on patient eligibility and formulary status |
| Quebec (RAMQ) | Tablets and hospital injectables | Varies | Verify with pharmacist and RAMQ formulary |
| British Columbia (PharmaCare) | Tablets, hospital injectables | May require special authority | Patient copay varies by plan |
| Alberta | Tablets and injectables | Varies | Check provincial formulary |
Step-By-Step Purchase Checklist For Canadian Patients
- Obtain a valid prescription from your prescriber.
- Ask your pharmacist to check the DIN and provincial formulary coverage.
- Confirm cost and generic options before filling.
- Request counselling on side effects, driving and interactions.
- Arrange follow-up with prescriber or pharmacist if symptoms persist or side effects occur.
Registration And Regulation
Health Canada Approval
What regulatory markings should be present on the product?
Products sold in Canada should display a Drug Identification Number (DIN) and be supplied as prescription medicines in accordance with federal and provincial rules.
Labels must meet federal and provincial requirements, with bilingual labelling considerations in some provinces.
DIN Number And Labelling Requirements
- Regulatory Responsibilities: Manufacturers must list accurate product monographs and ensure quality manufacturing.
- Regulatory Responsibilities: Prescribers should document indication and duration when prescribing off-label.
- Regulatory Responsibilities: Pharmacists must verify DIN, expiry and authenticity on the dispensed package.
- Regulatory Responsibilities: Patients should report serious adverse reactions to Canada Vigilance.
- Verification Checklist: Check the DIN, manufacturer name and expiry date on the package when collecting the medicine.
- Verification Checklist: Ask your pharmacist for a printout of the product monograph if uncertain about an indication or dosage.
Storage And Handling
Standard Canadian Household Conditions
How should prochlorperazine be stored at home?
Store tablets and suppositories at room temperature between 15°C and 30°C and protect them from moisture and light.
Keep all medicines out of the reach of children and in their original packaging when possible.
Cold-Chain Requirements Where Applicable
Do injectables need special storage?
Injectable prochlorperazine products should be handled according to the manufacturer and hospital pharmacy guidelines.
Follow aseptic preparation and storage instructions for parenteral doses in clinical settings.
| Product Type | Storage Temperature | Handling Notes |
|---|---|---|
| Tablets / Suppositories | 15–30°C | Store in original packaging; protect from moisture |
| Injectables | Follow manufacturer instructions | Hospital pharmacy to handle aseptically |
- Travel Checklist: Carry medication in carry-on luggage where possible and keep in original labelled container.
- Disposal: Return unused or expired medication to a pharmacy take-back program for safe disposal.
Guidelines For Proper Use
Canadian Pharmacist Guidance
What should pharmacists discuss when dispensing prochlorperazine?
Confirm the indication and ensure the patient understands the dosing schedule and missed-dose rules.
Warn the patient to avoid alcohol and to expect possible drowsiness, blurred vision and movement-related side effects.
Advise patients to stop the medicine and seek urgent care for acute dystonia, severe restlessness, high fever with rigidity or chest pain.
Provincial Health Authority Recommendations
How should clinicians monitor patients on prochlorperazine?
Short-term antiemetic use is usually less than seven days and requires routine follow-up only if symptoms persist.
Psychiatric indications require review within 2–4 weeks and periodic monitoring for metabolic and movement disorder side effects when used longer term.
- Patient Checklist When To Stop And Seek Help: Uncontrollable restlessness or sudden muscle spasms.
- Patient Checklist When To Stop And Seek Help: High fever with confusion or muscle stiffness.
- Clinician Checklist Baseline And Periodic Monitoring: Baseline vitals and metabolic panel for long-term use.
- Clinician Checklist Baseline And Periodic Monitoring: Regular movement disorder screening for tardive dyskinesia if therapy continues.
Delivery Across Canada (English)
| City | Region | Delivery time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Regina | Saskatchewan | 5-7 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
| Charlottetown | Prince Edward Island | 5-9 days |
| Yellowknife | Northwest Territories | 5-9 days |
| Iqaluit | Nunavut | 5-9 days |
| Whitehorse | Yukon | 5-9 days |
| Kelowna | British Columbia | 5-9 days |